Workflow
Aurora(ACB)
icon
Search documents
Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
MarketBeat· 2024-04-02 11:17
Key PointsSeveral cannabis stocks surged dramatically over the previous month, igniting the sector as gains reached double- to even triple-digits in some cases.Vice President Kamala Harris supports federal marijuana legalization and urged the DEA to reschedule the drug.Germany passed a law fully legalizing marijuana, effective April 1, including possession, home growing, and distribution among social clubs.5 stocks we like better than Canopy GrowthVarious themes and sectors garnered buzz and attention as th ...
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
Prnewswire· 2024-04-01 11:00
NASDAQ | TSX: ACB The Expected De-scheduling of Cannabis to Fuel Expansion of the Medical Cannabis Market in Germany EDMONTON, AB, April 1, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – a Canadian based leading global medical cannabis company, applauds the German government's final endorsement of cannabis legalization, marking a significant step forward in bolstering patient access to medical cannabis with the official passing of the Cannabis Act. This change presents long overdue ref ...
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
Prnewswire· 2024-03-20 11:15
Milestone Achievement Signals Company's Commitment to Solidifying its Leadership in the Australian Market                                                                                            NASDAQ | TSX: ACB EDMONTON, AB, March 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company has received Good Manufacturing Practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA) for its Canadian production f ...
Cannabis stocks rally as VP Harris calls on DEA to reschedule marijuana ‘as quickly as possible'
Proactive Investors· 2024-03-18 16:03
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Top Marijuana Stocks For Trading Today 2024
MarijuanaStocks· 2024-03-06 14:06
Could These Marijuana Stocks Run Today?More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculation is high in 2024 for those who are invested in legal cannabis. Political figures from all parties are starting to find common ground with the cannabis industry.With 2024 being an election year there is even more motivation to figure out how to pass federal reform. The am ...
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
InvestorPlace· 2024-03-04 23:42
Ordinarily, you’ll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound. Certain relevant enterprises may be liable to bounce back after bearish actions have gone too far.Whether you want to call them dead-cat bounces or snapback rallies, the principle is the same. After incurring long bouts of negativity, market participants might see value shift to the other side of the equation. Nothing stays perfectly linear forever, which und ...
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
Prnewswire· 2024-03-04 14:42
                                                                        NASDAQ | TSX: ACBCanada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for PatientsEDMONTON, AB, March 4, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescr ...
Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
Prnewswire· 2024-02-29 22:00
 NASDAQ | TSX: ACB EDMONTON, AB, Feb. 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an aggregate of approximately $7.2 million (US$5.3 million), representing the final payment on the principal amount of its convertible senior notes ("Notes") at a total cash cost of $7.4 million (~US$5.5 million), including accrued interest. Following the completion of this repayme ...
Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
Prnewswire· 2024-02-28 12:11
                                                                                                        NASDAQ | TSX: ACB Partnership will empower UK patients with valuable information and guidance critical to a successful cannabis experience   EDMONTON, AB, Feb. 28, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescri ...
Aurora Cannabis: Barely Surviving Or Soon To Be Thriving?
Seeking Alpha· 2024-02-28 00:50
Aleksandr_Kravtsov/iStock via Getty Images Aurora Cannabis (NASDAQ:ACB, ACB:CA) recently completed the consolidation of common shares on a 10:1 basis to maintain its minimum bid requirement to stay on the NASDAQ. This is the second time the company has done a reverse share split, with the first being back on May 11, 2020 on a 12:1 basis. StockCharts I previously suggested the company may turn around in 2023 and I may have been too early. But as absolutely bleak as the stock price chart looks there see ...